Abbott announces new real─world evidence linking Cologuard screening to lower colorectal cancer incidence and odds of death
Abbott announced new real─world evidence showing that completion of multitarget stool DNA (mt─sDNA) screening was associated with approximately 54% lower colorectal cancer incidence and 45% lower odds
Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.
Read full story on publisher site →